Fleury S.A.'s latest marketcap:
As of 07/05/2025, Fleury S.A.'s market capitalization has reached $1.29 B. According to our data, Fleury S.A. is the 8248th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.29 B |
| Revenue (ttm) | 1.43 B |
| Net Income (ttm) | 115.4 M |
| Shares Out | 545.02 M |
| EPS (ttm) | 0.21 |
| Forward PE | 10.15 |
| Ex-Dividend Date | 03/07/2025 |
| Earnings Date | 08/07/2025 |
Fleury S.A.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | R$1.29 B | 6.69% | 8248 |
| 12/30/2024 | R$6.57 B | -33.4% | 8495 |
| 12/28/2023 | R$9.86 B | 74.25% | 5562 |
| 12/29/2022 | R$5.66 B | -0.72% | 7949 |
| 12/30/2021 | R$5.7 B | -33.5% | 9229 |
| 12/30/2020 | R$8.58 B | -11.32% | 5991 |
| 12/30/2019 | R$9.67 B | 54.88% | 4054 |
| 12/28/2018 | R$6.24 B | -33.13% | 4602 |
| 12/28/2017 | R$9.34 B | 66.69% | 3633 |
| 12/29/2016 | R$5.6 B | 123.98% | 4400 |
Company Profile
About Fleury S.A.
Fleury S.A., along with its subsidiaries, delivers comprehensive medical services across Brazil, specializing in diagnostics, treatment, clinical analysis, health management, and specialized care in orthopedics and ophthalmology.
Business Segments
- Diagnostic Medicine: Laboratory and imaging tests, genomics, and diagnostic information services.
- Integrated Medicine: Health management, check-ups, clinic day services, infusion centers, and specialized orthopedic and ophthalmological care.
- Dental: Dental imaging tests and diagnostic imaging services.
Digital Healthcare Platform
The company offers Saúde I, a digital platform enabling teleconsultations, in-person appointments, diagnostic test scheduling, electronic medical records, and personalized health management.
Brand Portfolio
Fleury operates under multiple brand names, including Fleury, Felippe Mattoso, Labs a+, Diagnoson a+, Papaiz, Serdil, LAFE, and others, providing services through customer service units and hospital-based facilities.
Company Background
Founded in 1926, Fleury S.A. is headquartered in São Paulo, Brazil, and has established itself as a leader in the country's healthcare sector.
Frequently Asked Questions
-
What is Fleury S.A.'s (BVMF-FLRY3) current market cap?As of 07/05/2025, Fleury S.A. (including the parent company, if applicable) has an estimated market capitalization of $1.29 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Fleury S.A. (BVMF-FLRY3) rank globally by market cap?Fleury S.A. global market capitalization ranking is approximately 8248 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.